MI Bioresearch Revenue and Competitors

Detroit, MI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MI Bioresearch's estimated annual revenue is currently $47.3M per year.(i)
  • MI Bioresearch's estimated revenue per employee is $155,000

Employee Data

  • MI Bioresearch has 305 Employees.(i)
  • MI Bioresearch grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$177.6M71613%$62.1MN/A
#2
N/A55-15%$1.3MN/A
Add Company

MI Bioresearch (MI), formerly Molecular Imaging, Inc., is a preclinical oncology service provider, offering in vitro and in vivo pharmacology services, in vivo imaging technologies, and focal radiation capabilities to support your research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough. We have over 350 cell lines representing a wide array of histotypes for both human and syngeneic tumors. Our large cell line library allows us to perform a number of key in vitro services, such as, cell based assays, flow cytometry, phospho-flow, and immunohistochemistry. These assays provide in vitro proof-of-concept prior to in vivo studies or provide a means to interrogate ex vivo samples collected during a study. We have in vivo, historic data on more than a third of our cell line library, allowing us to work with clients in developing the optimal study design to answer the pertinent questions within their preclinical drug discovery programs. Where relevant, we can apply small animal in vivo imaging using CT, MRI, SPECT, PET, Bioluminescence Imaging, Fluorescence Imaging, 2D X-ray, DEXA, and targeted radiation using our in-house SARRP. When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools, and experience to help move life-changing drug candidates through preclinical development quickly and effectively. Tumor Models: SC, Disseminated, Orthotopic, Orthotopic Glioblastoma, Metastatic Careers: https://www.mibioresearch.com/about/careers/

keywords:N/A

N/A

Total Funding

305

Number of Employees

$47.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MI Bioresearch News

2022-04-17 - Global Pre-Clinical Contract Research Services Market 2022 ...

... Covance; EVOTEC; The Jackson Laboratory; MI Bioresearch; Champion Oncology; Xentech; Living Tumor Laboratory; JOINN Lab.

2022-04-17 - Global Clinical Contract Research Services Market 2022 ...

Inc. Labcorp; CRL; Crown Bioscience; Taconic Biosciences; Covance; EVOTEC; The Jackson Laboratory; MI Bioresearch; Champion Oncology; Xentech...

2022-04-17 - Global Preclinical CRO Services Market 2022 Ongoing Trend ...

The Jackson Laboratory; MI Bioresearch; Champion Oncology; Wuxi AppTec. Xentech; Living Tumor Laboratory; CrownBio. The worldwide Preclinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$69.5M309N/AN/A
#2
$56.9M3143%N/A
#3
$59.1M3153%N/A
#4
$110.1M3213%$50M
#5
$99M32222%N/A